- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 421/00 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
Patent holdings for IPC class C07D 421/00
Total number of patents in this class: 37
10-year publication summary
|
4
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3732 |
6 |
| Abbvie Inc. | 1802 |
4 |
| Bristol-myers Squibb Company | 4845 |
2 |
| Boehringer Ingelheim International GmbH | 4641 |
2 |
| Janssen Pharmaceutica N.V. | 3364 |
2 |
| AbbVie Deutschland GmbH & Co. KG | 264 |
2 |
| Samsung Electronics Co., Ltd. | 148173 |
1 |
| Hoffmann-La Roche Inc. | 3495 |
1 |
| Samsung SDI Co., Ltd. | 8811 |
1 |
| Vertex Pharmaceuticals Incorporated | 1626 |
1 |
| Almirall, S.A. | 493 |
1 |
| Biogen Idec MA Inc. | 179 |
1 |
| BioMarin Pharmaceutical Inc. | 375 |
1 |
| Neuren Pharmaceuticals Limited | 11 |
1 |
| Saniona AB | 1 |
1 |
| Suven Life Sciences Limited | 134 |
1 |
| University of East Anglia | 36 |
1 |
| Whitehead Institute for Biomedical Research | 321 |
1 |
| Yale University | 2421 |
1 |
| Pharmadiall Limited Liability Company | 1 |
1 |
| Other owners | 5 |